Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1977 May 1;145(5):1264–1277. doi: 10.1084/jem.145.5.1264

Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth

PMCID: PMC2180651  PMID: 404387

Abstract

Mice carrying any one of three murine tumors in their right hind foot pad were incapable of eliminating an inoculum of the bacterial parasite Listeria monocytogenes from the progressive tumor. In contrast, they were as capable as control mice in efficiently eliminating the organism from their contralateral tumor-free foot pad, and from their lymph nodes and livers. The results serve to show, therefore, that conditions within an established tumor are not only antagonistic to the expression of concomitant anti-tumor immunity, but that they are also antagonistic to the expression of T-cell-mediated anti-bacterial immunity. The possibility was discussed that the tumor contains factors that act pharmacologically to locally suppress the function of sensitized T cells and activated macrophages.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Embleton M. J., Robins R. A. Humoral factors influencing cell-mediated immune responses to tumour-associated antigens. Proc R Soc Med. 1973 May;66(5):466–468. [PMC free article] [PubMed] [Google Scholar]
  2. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  3. Bernstein I. D., Zbar B., Rapp H. J. Impaired inflammatory response in tumor-bearing guinea pigs. J Natl Cancer Inst. 1972 Dec;49(6):1641–1647. doi: 10.1093/jnci/49.6.1641. [DOI] [PubMed] [Google Scholar]
  4. DIZON Q. S., SOUTHAM C. M. ABNORMAL CELLULAR RESPONSE TO SKIN ABRASION IN CANCER PATIENTS. Cancer. 1963 Oct;16:1288–1292. doi: 10.1002/1097-0142(196310)16:10<1288::aid-cncr2820161009>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  5. Fauve R. M., Hevin B., Jacob H., Gaillard J. A., Jacob F. Antiinflammatory effects of murine malignant cells. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4052–4056. doi: 10.1073/pnas.71.10.4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gershon R. K., Carter R. L., Kondo K. On concomitant immunity in tumour-bearing hamsters. Nature. 1967 Feb 18;213(5077):674–676. doi: 10.1038/213674a0. [DOI] [PubMed] [Google Scholar]
  7. Hellström I., Sjögren H. O., Warner G., Hellström K. E. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971 Mar 15;7(2):226–237. doi: 10.1002/ijc.2910070206. [DOI] [PubMed] [Google Scholar]
  8. Hellström K. E., Hellström I. Cellular immunity against tumor antigens. Adv Cancer Res. 1969;12:167–223. doi: 10.1016/s0065-230x(08)60331-0. [DOI] [PubMed] [Google Scholar]
  9. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol. 1972 Jan 12;235(54):48–50. doi: 10.1038/newbio235048a0. [DOI] [PubMed] [Google Scholar]
  10. Johnson M. W., Maibach H. I., Salmon S. E. Brief communication: quantitative impairment of primary inflammatory response in patients with cancer. J Natl Cancer Inst. 1973 Sep;51(3):1075–1076. doi: 10.1093/jnci/51.3.1075. [DOI] [PubMed] [Google Scholar]
  11. Kearney R., Basten A., Nelson D. S. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer. 1975 Mar 15;15(3):438–450. doi: 10.1002/ijc.2910150310. [DOI] [PubMed] [Google Scholar]
  12. Keller R. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J Exp Med. 1973 Sep 1;138(3):625–644. doi: 10.1084/jem.138.3.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MAHONEY M. J., LEIGHTON J. The inflammatory response to a foreign body within transplantable tumors. Cancer Res. 1962 Apr;22:334–338. [PubMed] [Google Scholar]
  14. North R. J., Kirstein D. P. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites. J Exp Med. 1977 Feb 1;145(2):275–292. doi: 10.1084/jem.145.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976 Mar 1;143(3):559–573. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity. J Exp Med. 1976 Mar 1;143(3):574–584. doi: 10.1084/jem.143.3.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. OLD L. J., CLARKE D. A., BENACERRAF B., GOLDSMITH M. The reticuloendothelial system and the neoplastic process. Ann N Y Acad Sci. 1960 Jun 21;88:264–280. doi: 10.1111/j.1749-6632.1960.tb20026.x. [DOI] [PubMed] [Google Scholar]
  18. Pierce G. E. Enhanced growth of primary Moloney virus-induced sarcomas in mice. Int J Cancer. 1971 Jul 15;8(1):22–31. doi: 10.1002/ijc.2910080104. [DOI] [PubMed] [Google Scholar]
  19. Pike M. C., Snyderman R. Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol. 1976 Oct;117(4):1243–1249. [PubMed] [Google Scholar]
  20. Snyderman R., Pike M. C., Blaylock B. L., Weinstein P. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J Immunol. 1976 Mar;116(3):585–589. [PubMed] [Google Scholar]
  21. Vaage J. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue. Cancer Res. 1971 Nov;31(11):1655–1662. [PubMed] [Google Scholar]
  22. Youdim S., Moser M., Stutman O. Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes. J Natl Cancer Inst. 1974 Jan;52(1):193–198. doi: 10.1093/jnci/52.1.193. [DOI] [PubMed] [Google Scholar]
  23. Zbar B., Bernstein I. D., Bartlett G. L., Hanna M. G., Jr, Rapp H. J. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. J Natl Cancer Inst. 1972 Jul;49(1):119–130. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES